Daniel B. Mark, MD, MPH, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis Corporation(MODEST) OTHER FINANCIAL BENEFIT: Elsevier(SIGNIFICANT)

View Full Disclosure